Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region

NCT ID: NCT04288531

Last Updated: 2024-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

304 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-10

Study Completion Date

2026-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Full intellectual capabilities are achieved only if crucial nutrients are present during development. Iodine deficiency is the most common cause of preventable brain harm in infants. Because of its critical need during pregnancy, several countries implemented programs of iodine supplementation in preconception and pregnancy. In 2013, the prevalence of iodine deficiency in Portugal has led health authorities to issue a recommendation for iodine supplementation. This study aims to evaluate the impact of iodine supplementation on maternal and fetal iodine status and thyroid function, obstetric outcomes, quality of breast milk and child psychomotor development. It also intends to evaluate whether the time of iodine supplementation initiation influences all the above-mentioned parameters. The novelty and relevance of this study reside on the number of women/child and on the extent of health parameters that will be evaluated. The information collected will contribute to the detailed characterization of thyroid hormone homeostasis throughout pregnancy and its relationship with iodine supplementation (including time of initiation). The data will provide evidence on whether this iodine supplementation strategy impacted on iodine sufficiency of the mother and the newborns, or if it needs re-evaluation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Iodine is essential for intellectual development. Its deficiency, alone, is the most frequent cause of preventable brain harm in infants. Iodine is required to synthesize thyroid hormones, key components of central nervous system development. Because of its relevance in pregnancy, several countries have implemented iodine supplementation programs in preconception, pregnancy and lactation.

Iodine deficiency has been previously shown in women of childbearing age in Portugal. Because of this, since 2013 the National Health Authorities have recommended supplementing iodine (200 ug/day) in preconception, pregnant and lactating women. However, the latest Cochrane review on the subject does not allow to conclude on whether iodine supplementation strategies implemented to date are efficient. Therefore, this study is of great public health interest.

The objectives are to:

* Evaluate whether the new policy of recommending iodine supplementation in preconception, throughout pregnancy and during lactation impacted on the prevalence of iodine deficiency in the Minho region of Portugal when compared to the same population before the recommendation.
* Evaluate whether the time of initiation of iodine supplementation (if any) influences the serum levels of thyroid hormones in the three trimesters of pregnancy.
* Evaluate whether the serum levels of thyroid hormones in the first trimester of pregnancy predict psychomotor development of the newborn at 12 months of age.

To achieve these aims the investigators will follow: i) 304 women longitudinally, before, during the three trimesters of pregnancy (primary care Health Centres), at delivery and three months after delivery, ii) their children at birth, 3 and 12 months of age; ii) perform a detailed evaluation of parameters of thyroid function (mother and child) and of psychomotor development of the newborns.

Investigators expect to provide detailed characterization of thyroid hormone homeostasis before and throughout pregnancy, their relation with iodine supplementation (and its timing of administration, if any) and with thyroid hormone parameters and psychomotor development of the newborn.

With 6 years passed since the beginning of recommendation on iodine supplementation, this is an appropriate time to assess its effectiveness. The high number of samples and parameters to analyze make this a high-power study to support public health policies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iodine Deficiency Thyroid Pregnancy Related Psychomotor Impairment Hypothyroidism in Pregnancy Nutrient Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant and pregnant to be on iodine supplementation

Women in preconception, pregnant and lactating, receiving iodine supplementation

Iodine supplementation

Intervention Type DIETARY_SUPPLEMENT

Recommendation, issued by the National Health Authorities, on supplementing with iodine (200 ug/day) women during preconception, pregnancy and lactation.

Pregnant and pregnant to be not on iodine supplementation

Women in preconception, pregnant or lactating, not receiving iodine supplementation

No interventions assigned to this group

Women of childbearing age

Women of childbearing age not planning to become pregnant.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Iodine supplementation

Recommendation, issued by the National Health Authorities, on supplementing with iodine (200 ug/day) women during preconception, pregnancy and lactation.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women of who intend to become pregnant or are pregnant, able to read, write and provide informed consent

Exclusion Criteria

* Women transferred from outside the study health centres during pregnancy and women taking iodine supplementation before recruitment.
* Women not intending to deliver at Hospital de Braga.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto Nacional de Saúde Dr Ricardo Jorge, Portugal

UNKNOWN

Sponsor Role collaborator

Clinical Academic Center (2CA-Braga)

OTHER

Sponsor Role collaborator

Hospital de Braga

OTHER

Sponsor Role collaborator

Administração Regional de Saúde do Norte, Portugal

OTHER

Sponsor Role collaborator

University of Minho

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Joana Almeida Palha

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joana A Palha, PhD

Role: PRINCIPAL_INVESTIGATOR

School of Medicine, University of Minho

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Usf Maxisaude

Braga, , Portugal

Site Status

Usf Braga Norte

Braga, , Portugal

Site Status

Usf Ruães

Braga, , Portugal

Site Status

Usf S. Lourenço

Braga, , Portugal

Site Status

Usf Gualtar

Braga, , Portugal

Site Status

Usf + Carandá

Braga, , Portugal

Site Status

Usf Manuel Rocha Peixoto

Braga, , Portugal

Site Status

Usf Bracara Augusta

Braga, , Portugal

Site Status

Usf Do Minho

Braga, , Portugal

Site Status

Usf S. João de Braga

Braga, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

References

Explore related publications, articles, or registry entries linked to this study.

Lopes-Pereira M, Roque S, Costa P, Quialheiro A, Santos NC, Goios A, Vilarinho L, Correia-Neves M, Palha JA. Impact of iodine supplementation during preconception, pregnancy and lactation on maternal thyroid homeostasis and offspring psychomotor development: protocol of the IodineMinho prospective study. BMC Pregnancy Childbirth. 2020 Nov 13;20(1):693. doi: 10.1186/s12884-020-03376-y.

Reference Type DERIVED
PMID: 33187482 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1247-2293

Identifier Type: OTHER

Identifier Source: secondary_id

UMinho-IodineMinho

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Iodine Supplementation in Obesity
NCT01985204 COMPLETED NA
Subclinical Hypothyroidism and Mind in the Elderly
NCT00921050 COMPLETED PHASE2/PHASE3